SNT 3.33% 3.1¢ syntara limited

ph 3 trial fails primary endpoint, page-13

  1. 1,656 Posts.
    lightbulb Created with Sketch. 33
    Another sad day for the Biotech sector. Falling over at Ph3 trials after years of promising progress and lost loyal investors money. Who would invest in Biotechs now with so many failures in the sector. Im just pleased Lopez isn't around to rub it in.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $40.00M
Open High Low Value Volume
3.0¢ 3.1¢ 3.0¢ $16.17K 538.6K

Buyers (Bids)

No. Vol. Price($)
3 366566 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 422617 4
View Market Depth
Last trade - 15.57pm 06/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.